annual CFO:
$157.72M+$141.02M(+844.31%)Summary
- As of today (August 31, 2025), ACAD annual cash flow from operations is $157.72 million, with the most recent change of +$141.02 million (+844.31%) on December 31, 2024.
- During the last 3 years, ACAD annual CFO has risen by +$283.38 million (+225.51%).
- ACAD annual CFO is now at all-time high.
Performance
ACAD Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$63.96M+$43.63M(+214.70%)Summary
- As of today (August 31, 2025), ACAD quarterly cash flow from operations is $63.96 million, with the most recent change of +$43.63 million (+214.70%) on June 30, 2025.
- Over the past year, ACAD quarterly CFO has increased by +$38.94 million (+155.69%).
- ACAD quarterly CFO is now -25.10% below its all-time high of $85.39 million, reached on December 31, 2023.
Performance
ACAD quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$187.91M+$38.94M(+26.14%)Summary
- As of today (August 31, 2025), ACAD TTM cash flow from operations is $187.91 million, with the most recent change of +$38.94 million (+26.14%) on June 30, 2025.
- Over the past year, ACAD TTM CFO has increased by +$107.38 million (+133.35%).
- ACAD TTM CFO is now -7.31% below its all-time high of $202.73 million, reached on September 30, 2024.
Performance
ACAD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ACAD Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +844.3% | +155.7% | +133.3% |
| 3 y3 years | +225.5% | +587.3% | +244.9% |
| 5 y5 years | +204.4% | +273.4% | +239.8% |
ACAD Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +225.5% | -25.1% | +208.5% | -7.3% | +244.9% |
| 5 y | 5-year | at high | +204.4% | -25.1% | +183.8% | -7.3% | +227.6% |
| alltime | all time | at high | +172.4% | -25.1% | +183.8% | -7.3% | +174.8% |
ACAD Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $63.96M(+214.7%) | $187.91M(+26.1%) |
| Mar 2025 | - | $20.32M(-49.7%) | $148.96M(-5.6%) |
| Dec 2024 | $157.72M(+844.3%) | $40.38M(-36.2%) | $157.72M(-22.2%) |
| Sep 2024 | - | $63.25M(+152.9%) | $202.73M(+151.8%) |
| Jun 2024 | - | $25.01M(-14.0%) | $80.53M(+26.4%) |
| Mar 2024 | - | $29.08M(-65.9%) | $63.71M(+281.5%) |
| Dec 2023 | $16.70M(-114.6%) | $85.39M(-244.8%) | $16.70M(-118.0%) |
| Sep 2023 | - | -$58.95M(-818.9%) | -$92.54M(+169.7%) |
| Jun 2023 | - | $8.20M(-145.7%) | -$34.31M(-38.3%) |
| Mar 2023 | - | -$17.93M(-24.8%) | -$55.64M(-51.2%) |
| Dec 2022 | -$114.03M(-9.3%) | -$23.85M(+3181.2%) | -$114.03M(+0.6%) |
| Sep 2022 | - | -$727.00K(-94.5%) | -$113.30M(-12.6%) |
| Jun 2022 | - | -$13.13M(-82.8%) | -$129.64M(-8.6%) |
| Mar 2022 | - | -$76.33M(+230.1%) | -$141.84M(+12.9%) |
| Dec 2021 | -$125.66M(-7.7%) | -$23.12M(+35.5%) | -$125.66M(-3.4%) |
| Sep 2021 | - | -$17.06M(-32.6%) | -$130.03M(-4.2%) |
| Jun 2021 | - | -$25.33M(-57.9%) | -$135.76M(-7.8%) |
| Mar 2021 | - | -$60.15M(+118.8%) | -$147.31M(+8.2%) |
| Dec 2020 | -$136.17M(-9.9%) | -$27.49M(+20.6%) | -$136.17M(-1.6%) |
| Sep 2020 | - | -$22.79M(-38.2%) | -$138.38M(+2.9%) |
| Jun 2020 | - | -$36.88M(-24.7%) | -$134.44M(-1.1%) |
| Mar 2020 | - | -$49.00M(+65.0%) | -$135.96M(-10.0%) |
| Dec 2019 | -$151.13M(-9.8%) | -$29.71M(+57.6%) | -$151.13M(-5.8%) |
| Sep 2019 | - | -$18.85M(-50.9%) | -$160.50M(-12.7%) |
| Jun 2019 | - | -$38.40M(-40.2%) | -$183.93M(-1.3%) |
| Mar 2019 | - | -$64.17M(+64.2%) | -$186.41M(+11.3%) |
| Dec 2018 | -$167.47M(-23.1%) | -$39.08M(-7.6%) | -$167.47M(+5.8%) |
| Sep 2018 | - | -$42.28M(+3.4%) | -$158.29M(-9.2%) |
| Jun 2018 | - | -$40.88M(-9.6%) | -$174.41M(-9.4%) |
| Mar 2018 | - | -$45.24M(+51.3%) | -$192.43M(-11.6%) |
| Dec 2017 | -$217.76M(+4.5%) | -$29.89M(-48.8%) | -$217.76M(-13.3%) |
| Sep 2017 | - | -$58.40M(-0.8%) | -$251.05M(+3.8%) |
| Jun 2017 | - | -$58.90M(-16.5%) | -$241.91M(+1.7%) |
| Mar 2017 | - | -$70.56M(+11.7%) | -$237.76M(+14.1%) |
| Dec 2016 | -$208.41M(+71.6%) | -$63.19M(+28.3%) | -$208.41M(+16.1%) |
| Sep 2016 | - | -$49.26M(-10.0%) | -$179.57M(+10.7%) |
| Jun 2016 | - | -$54.74M(+32.8%) | -$162.16M(+18.1%) |
| Mar 2016 | - | -$41.21M(+20.0%) | -$137.29M(+13.1%) |
| Dec 2015 | -$121.42M(+82.8%) | -$34.35M(+7.8%) | -$121.42M(+15.8%) |
| Sep 2015 | - | -$31.85M(+6.6%) | -$104.87M(+15.9%) |
| Jun 2015 | - | -$29.87M(+17.9%) | -$90.50M(+16.6%) |
| Mar 2015 | - | -$25.35M(+42.4%) | -$77.60M(+16.8%) |
| Dec 2014 | -$66.43M(+109.1%) | -$17.80M(+1.8%) | -$66.43M(+12.8%) |
| Sep 2014 | - | -$17.48M(+3.0%) | -$58.90M(+15.7%) |
| Jun 2014 | - | -$16.97M(+19.6%) | -$50.89M(+29.3%) |
| Mar 2014 | - | -$14.18M(+38.2%) | -$39.37M(+23.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$31.77M(+46.9%) | -$10.27M(+8.3%) | -$31.77M(+14.3%) |
| Sep 2013 | - | -$9.47M(+74.0%) | -$27.80M(+17.6%) |
| Jun 2013 | - | -$5.44M(-17.3%) | -$23.63M(+2.8%) |
| Mar 2013 | - | -$6.58M(+4.6%) | -$22.99M(+6.3%) |
| Dec 2012 | -$21.63M(+8.7%) | -$6.30M(+18.7%) | -$21.63M(+4.6%) |
| Sep 2012 | - | -$5.31M(+10.5%) | -$20.67M(+5.8%) |
| Jun 2012 | - | -$4.80M(-8.2%) | -$19.54M(-2.4%) |
| Mar 2012 | - | -$5.23M(-2.0%) | -$20.02M(+0.6%) |
| Dec 2011 | -$19.90M(+85.9%) | -$5.34M(+27.9%) | -$19.90M(+99.9%) |
| Sep 2011 | - | -$4.17M(-21.0%) | -$9.96M(+19.9%) |
| Jun 2011 | - | -$5.28M(+3.4%) | -$8.30M(-11.3%) |
| Mar 2011 | - | -$5.11M(-210.9%) | -$9.36M(-12.6%) |
| Dec 2010 | -$10.70M(-22.0%) | $4.60M(-282.6%) | -$10.70M(-55.6%) |
| Sep 2010 | - | -$2.52M(-60.2%) | -$24.08M(-27.5%) |
| Jun 2010 | - | -$6.33M(-1.8%) | -$33.22M(+382.1%) |
| Mar 2010 | - | -$6.45M(-26.5%) | -$6.89M(-49.8%) |
| Dec 2009 | -$13.73M(-78.8%) | -$8.77M(-24.8%) | -$13.73M(-20.3%) |
| Sep 2009 | - | -$11.66M(-158.3%) | -$17.23M(-19.5%) |
| Jun 2009 | - | $20.00M(-250.5%) | -$21.41M(-62.8%) |
| Mar 2009 | - | -$13.29M(+8.3%) | -$57.61M(-11.2%) |
| Dec 2008 | -$64.87M(+18.1%) | -$12.27M(-22.5%) | -$64.87M(-2.4%) |
| Sep 2008 | - | -$15.84M(-2.2%) | -$66.47M(+4.2%) |
| Jun 2008 | - | -$16.21M(-21.1%) | -$63.76M(+4.1%) |
| Mar 2008 | - | -$20.55M(+48.2%) | -$61.25M(+11.5%) |
| Dec 2007 | -$54.93M(+32.6%) | -$13.87M(+5.5%) | -$54.93M(+2.5%) |
| Sep 2007 | - | -$13.14M(-4.0%) | -$53.60M(+2.0%) |
| Jun 2007 | - | -$13.69M(-3.7%) | -$52.56M(+10.3%) |
| Mar 2007 | - | -$14.22M(+13.4%) | -$47.68M(+15.1%) |
| Dec 2006 | -$41.42M(+104.4%) | -$12.54M(+3.6%) | -$41.42M(+15.3%) |
| Sep 2006 | - | -$12.11M(+37.5%) | -$35.91M(+19.4%) |
| Jun 2006 | - | -$8.80M(+10.5%) | -$30.07M(+7.5%) |
| Mar 2006 | - | -$7.96M(+13.2%) | -$27.96M(+38.0%) |
| Dec 2005 | -$20.26M(-2.1%) | -$7.03M(+12.3%) | -$20.26M(+53.2%) |
| Sep 2005 | - | -$6.26M(-6.5%) | -$13.23M(+90.0%) |
| Jun 2005 | - | -$6.70M(+2400.7%) | -$6.96M(+34.8%) |
| Mar 2005 | - | -$267.80K(-94.5%) | -$5.17M(-65.3%) |
| Dec 2004 | -$20.69M(+110.8%) | - | - |
| Jun 2004 | - | -$4.90M(+25.6%) | -$14.90M(+22.0%) |
| Mar 2004 | - | -$3.90M(+19.1%) | -$12.21M(+24.4%) |
| Dec 2003 | -$9.82M(+6.2%) | -$3.28M(+16.2%) | -$9.82M(+50.1%) |
| Sep 2003 | - | -$2.82M(+27.6%) | -$6.54M(+75.7%) |
| Jun 2003 | - | -$2.21M(+46.0%) | -$3.72M(+146.0%) |
| Mar 2003 | - | -$1.51M | -$1.51M |
| Dec 2002 | -$9.24M(-18.2%) | - | - |
| Dec 2001 | -$11.29M(-144.6%) | - | - |
| Dec 2000 | $25.33M | - | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual cash flow from operations?
- What is the all time high annual CFO for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual CFO year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly CFO year-on-year change?
- What is ACADIA Pharmaceuticals Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. TTM CFO year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual cash flow from operations?
The current annual CFO of ACAD is $157.72M
What is the all time high annual CFO for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual cash flow from operations is $157.72M
What is ACADIA Pharmaceuticals Inc. annual CFO year-on-year change?
Over the past year, ACAD annual cash flow from operations has changed by +$141.02M (+844.31%)
What is ACADIA Pharmaceuticals Inc. quarterly cash flow from operations?
The current quarterly CFO of ACAD is $63.96M
What is the all time high quarterly CFO for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly cash flow from operations is $85.39M
What is ACADIA Pharmaceuticals Inc. quarterly CFO year-on-year change?
Over the past year, ACAD quarterly cash flow from operations has changed by +$38.94M (+155.69%)
What is ACADIA Pharmaceuticals Inc. TTM cash flow from operations?
The current TTM CFO of ACAD is $187.91M
What is the all time high TTM CFO for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high TTM cash flow from operations is $202.73M
What is ACADIA Pharmaceuticals Inc. TTM CFO year-on-year change?
Over the past year, ACAD TTM cash flow from operations has changed by +$107.38M (+133.35%)